Answers are grounded in this paper and cite their sources.
Narrative review highlights bioleaching for recovering palladium from secondary industrial waste, suggesting sustainable supply pathways for biomedical manufacturing.
Platinum group of metals (PGMs) are extensively used in numerous arenas as they have discrete physical and chemical properties. Platinum, Palladium, Rhodium, Ruthenium, Iridium, and Osmium are the precise metals that have high catalytic activities, significant electrical conductivity, and high corrosion resistance. Based on the conventional technologies to recover platinum group of metals, several methodologies have been suggestively enhanced. Due to the lack of primary sources and the increased economic value of these precise metals such as Palladium, it is crucial to recover these metals from different secondary resources, like, spent automotive catalytic converters, waste electronic and electrical instruments, used batteries, various low-grade ores, etc. Compared with traditional separation processes, the bioleaching technology with varying parametric conditions has rewards in terms of significant recovery efficiency, economically beneficial, good mechanism of desorption, and renewability. This overview inaugurates by introducing the platinum group of metals (PGMs) mainly palladium with their various application towards biomedical usage. Subsequently, the assessment of the recovery of palladium using bioleaching has been discussed in this synopsis.
No takes yet. Share an insight, caveat, or question.
Suman Saha (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: